Nutri Pharmaceuticals Research Inc
Resilient Healthcare Corp engages in the manufacture and sale of health, beauty, and food ingredients, as well as vitamins and supplements worldwide. It also develops a process that transforms edible oils into a free-flowing powder form. The company uses its "oil to powder' products as ingredients in finished goods, such as food, pet food, nutraceuticals or vitamin supplements, cosmetics, and org… Read more
Nutri Pharmaceuticals Research Inc (NRPR) - Total Assets
Latest total assets as of December 2003: $675.99K USD
Based on the latest financial reports, Nutri Pharmaceuticals Research Inc (NRPR) holds total assets worth $675.99K USD as of December 2003.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Nutri Pharmaceuticals Research Inc - Total Assets Trend (2003–2003)
This chart illustrates how Nutri Pharmaceuticals Research Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Nutri Pharmaceuticals Research Inc - Asset Composition Analysis
Current Asset Composition (December 2003)
Nutri Pharmaceuticals Research Inc's total assets of $675.99K consist of 70.1% current assets and 29.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 13.3% |
| Accounts Receivable | $125.01K | 18.5% |
| Inventory | $259.07K | 38.3% |
| Property, Plant & Equipment | $197.29K | 29.2% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2003–2003)
This chart illustrates how Nutri Pharmaceuticals Research Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Asset Diversification: The largest asset category is inventory at 38.3% of total assets.
Nutri Pharmaceuticals Research Inc Competitors by Total Assets
Key competitors of Nutri Pharmaceuticals Research Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
UCrest Bhd
KLSE:0005
|
Malaysia | RM48.46 Million |
|
Vanfund Urban Investment & Development Co Ltd
SHE:000638
|
China | CN¥265.74 Million |
|
BIT Computer Co. Ltd
KQ:032850
|
Korea | ₩82.38 Billion |
|
ezCaretech Co. LTD
KQ:099750
|
Korea | ₩56.71 Billion |
|
SyntekaBio Inc
KQ:226330
|
Korea | ₩33.49 Billion |
|
Carelabs Co.Ltd
KQ:263700
|
Korea | ₩105.15 Billion |
|
Shanghai Kingstar Winning Software
SHE:300253
|
China | CN¥8.35 Billion |
|
Longmaster Information Tech
SHE:300288
|
China | CN¥1.33 Billion |
Nutri Pharmaceuticals Research Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Nutri Pharmaceuticals Research Inc generates 0.19x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Nutri Pharmaceuticals Research Inc is currently not profitable relative to its asset base.
Nutri Pharmaceuticals Research Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.08 | - | - |
| Quick Ratio | 0.49 | - | - |
| Cash Ratio | 0.00 | - | - |
| Working Capital | $36.51K | - | - |
Nutri Pharmaceuticals Research Inc - Advanced Valuation Insights
This section examines the relationship between Nutri Pharmaceuticals Research Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 0.0% |
| Total Assets | $675.99K |
| Market Capitalization | $197.02 USD |
Valuation Analysis
Below Book Valuation: The market values Nutri Pharmaceuticals Research Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Nutri Pharmaceuticals Research Inc's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Nutri Pharmaceuticals Research Inc (2003–2003)
The table below shows the annual total assets of Nutri Pharmaceuticals Research Inc from 2003 to 2003.
| Year | Total Assets | Change |
|---|---|---|
| 2003-12-31 | $675.99K | -- |